Celldex Therapeutics has halted work on its solid-tumor-focused bispecific as the biotech prioritizes its work in ...

ADC Therapeutics has stopped development of lead solid tumor candidate ADCT-601. The biotech axed the AXL-directed ...

Cavite Extension project is set to open later this month, the Department of Transportation (DoTr) said on Thursday. In a ...

MannKind (MNKD) announced the successful completion of its first-in-human Phase 1 study of nintedanib DPI, or MNKD-201, for pulmonary fibrotic ...

Line 1 Cavite Extension is set to open this November, Transportation Secretary Jaime Bautista confirmed on Thursday. In a ...

The study is evaluating AJ1-11095, a novel agent for the treatment of myelofibrosis that did not respond to or relapsed ...

Transportation Secretary Jaime Bautista on Thursday announced the partial opening of the first segment of LRT-1 Cavite ...

Diving deeper into the financial backgrounds of the candidates, the report by Jharkhand Election Watch and the Association ...

The Shipyard Project is coming to fruition. Here's what you can now experience there as Phase 1 is complete. Plus, the massive step forward the city plans to take in Phase 2.

Lexeo Therapeutics (LXEO) announced positive interim results from the Phase 1/2 study of LX1001 for the treatment of APOE4-associated ...

Amrita Vishwa Vidyapeetham has announced dates for the first phase of the Amrita Entrance Examination – Engineering (AEEE) ...

Bright Minds Biosciences' BMB-101 shows promise in treating drug-resistant epilepsy. Read why DRUG stock is a strong ...